Clinical Trial Update: Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma

View source ↗

Summary

A translational study evaluating BRAFV600 serum and plasma levels in patients with BRAFV600 metastatic melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Grupo Español Multidisciplinar de Melanoma | Conditions: Stage IV Skin Melanoma | Status: COMPLETED